Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-03-07 @ 2:14 PM
Study NCT ID:
NCT05136404
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2021-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants
Sponsor:
Loxo Oncology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
17821
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |